-
Product Insights
NewAdvanced Glycosylation End Product Specific Receptor – Drugs In Development, 2024
The Advanced Glycosylation End Product Specific Receptor pipeline drugs market research report outlays comprehensive information on the Advanced Glycosylation End Product Specific Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Respiratory, Immunology, and Oncology which include indications of Alzheimer's Disease, Cognitive Disorders, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rheumatoid Arthritis, Acute Inflammation, Breast...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adebrelimab in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adebrelimab in Advanced Malignancy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adebrelimab in Advanced Malignancy Drug Details: Adebrelimab (Ariely) is a humanized...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dalnicastobart in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dalnicastobart in Advanced Malignancy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dalnicastobart in Advanced Malignancy Drug Details: Dalnicastobart (LVGN-7409) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Exlinkibart in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Exlinkibart in Advanced Malignancy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Exlinkibart in Advanced Malignancy Drug Details: Exlinkibart (LVGN-6051) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fianlimab in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fianlimab in Advanced Malignancy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fianlimab in Advanced Malignancy Drug Details: Fianlimab is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMXI-5001 in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMXI-5001 in Advanced Malignancy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMXI-5001 in Advanced Malignancy Drug Details: AMXI-5001 is under development for...
-
Product Insights
NewAdvanced Accelerator Applications SA Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Advanced Accelerator Applications SA Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company develops new medicines which targets the orphan diseases in the field of cardiology, oncology, neurology and inflammation. It is also involved in manufacturing Positron Emission tomography (PET) and single-photon emission computed tomography (SPECT). It’s...
-
Product Insights
NewAdvanced Medical Electronics Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Advanced Medical Electronics Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Advanced Medical Electronics Corp (AME) is a medical device company that provide research and development services. The company‘s products include electrocardiograph and spirometer equipment. It also provides battery powered surgical headlamp, wrist-worn pulse oximeter, electroencephalograph, partial polysomnograph, diagnostic spirometer and computerized visual acuity testing. AME offers services such as systems design, embedded design, electronics and instrumentation design, wireless...
-
Product Insights
Innovations in Advanced Ablation Catheters – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Advanced Ablation Catheters - Global Pipeline Summary" provides comprehensive information about the Advanced Ablation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Advanced Ablation Catheters report provides key information and data related to: Extensive coverage of the Advanced Ablation Catheters under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental...
-
Analyst Opinions
Advanced Barrier Packaging – Industry Insights
Reasons to buy the ‘Advanced Barrier Packaging’ industry insight report: The report is driven by GlobalData's Mega-trend Survey Analysis, primary consumer research that periodically compares the magnitude of each trend and its impact on consumer behavior. Understand the eight mega-trends, namely health & wellness, sensory & indulgence, sustainability & ethics, digitalization, individualism & expression, easy & affordable, comfort & uncertainty, and demographics, and their impact on consumer purchasing behavior. The outcomes of the survey allow us to determine the extent...